CEMIP1 and TACSTD2 as circulating mRNA biomarkers for early detection and tumor burden assessment in colorectal neoplasia.
- DOI
- 10.1186/s10020-026-01537-x
- Published
- 2026 Jun 25
- Container
- Molecular medicine (Cambridge, Mass.)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s10020-026-01537-x,
title = {CEMIP1 and TACSTD2 as circulating mRNA biomarkers for early detection and tumor burden assessment in colorectal neoplasia.},
author = {Balounova K and Uttarilli A and Horak J and Makajevova V and Sojka L and Simsa J and Bruha J and Liska V and Selvi S and Korenkova V and Vodenkova S and Jungwirth J and Macinga P and Hucl T and Kral J and Schneiderova M and Valickova A and Vymetalkova V},
year = {2026},
journal = {Molecular medicine (Cambridge, Mass.)},
doi = {10.1186/s10020-026-01537-x},
url = {https://doi.org/10.1186/s10020-026-01537-x}
}RIS
TY - JOUR TI - CEMIP1 and TACSTD2 as circulating mRNA biomarkers for early detection and tumor burden assessment in colorectal neoplasia. AU - Balounova K AU - Uttarilli A AU - Horak J AU - Makajevova V AU - Sojka L AU - Simsa J AU - Bruha J AU - Liska V AU - Selvi S AU - Korenkova V AU - Vodenkova S AU - Jungwirth J AU - Macinga P AU - Hucl T AU - Kral J AU - Schneiderova M AU - Valickova A AU - Vymetalkova V PY - 2026 JO - Molecular medicine (Cambridge, Mass.) DO - 10.1186/s10020-026-01537-x UR - https://doi.org/10.1186/s10020-026-01537-x ER -
APA
K, B., A, U., J, H., V, M., L, S., J, S., J, B., V, L., S, S., V, K., S, V., J, J., P, M., T, H., J, K., M, S., A, V., & V, V. (2026). CEMIP1 and TACSTD2 as circulating mRNA biomarkers for early detection and tumor burden assessment in colorectal neoplasia.. Molecular medicine (Cambridge, Mass.). https://doi.org/10.1186/s10020-026-01537-x
Source records
- pubmed · retrieved 2026-09-26T05:02:17.592Z